Chromogranin A (CgA) in the Diagnosis and Monitoring of Patients with Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NET): A Single-Institution Experience

被引：0
|
作者：
Massironi, S. [1 ]
Rossi, R. E.
Spampatti, M. P.
Casazza, G. [2 ]
Conte, D.
Ciafardini, C.
Cavalcoli, F.
Peracchi, M.
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[2] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
cga; gep-net;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [31] Somatostatin analogs (SSA) treatment in G1-G2 gastroenteropancreatic neuroendocrine tumors (GEP-NET): A single centre experience
    Marconcini, R.
    Ricci, S.
    Galli, L.
    Antonuzzo, A.
    Derosa, L.
    Farnesi, A.
    Biasco, E.
    Vasile, E.
    Caponi, S.
    Falcone, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S633 - S633
  • [32] A single institution experience with neuroendocrine tumors
    Badari, A. Badari
    Javle, M.
    Pak, Y.
    Khoury, T.
    Ramnath, N.
    Gibbs, J.
    Kuvshinoff, B.
    Iyer, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Gastroenteropancreatic neuroendocrine tumors: A single-centre experience
    Hadjer, A.
    Saidi, A.
    Ghomari-Bezzar, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S201 - S201
  • [34] Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET) [Chirurgie neuroendokriner tumoren des gastroenteropankreatischen systems (GEP-NET)]
    Goretzki P.E.
    Starke A.
    Akca A.
    Lammers B.J.
    Der Internist, 2012, 53 (2): : 152 - 160
  • [35] Chromogranin A as a Marker for Diagnosis, Treatment, and Survival in Patients With Gastroenteropancreatic Neuroendocrine Neoplasm
    Wang, Yu-hong
    Yang, Qiu-chen
    Lin, Yuan
    Xue, Ling
    Chen, Min-hu
    Chen, Jie
    MEDICINE, 2014, 93 (27)
  • [36] Radio-Guided Surgery for the Intraoperative Detection of Neuroendocrine Tumors of the Gastroenteropancreatic Tract (GEP/NET)
    Szybinski, P.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Klek, S.
    Froess-Baron, K.
    Mikolajczak, R.
    Kulig, J.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 138 - 138
  • [37] Predictive factors of efficacy of Somatostatine Analogs (SSA) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET)
    Ricci, S.
    Marconcini, R.
    Galli, L.
    Antonuzzo, A.
    Farnesi, A.
    Derosa, L.
    Biasco, E.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 143 - 143
  • [38] Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience
    Ambe, Chenwi M.
    Phuong Nguyen
    Centeno, Barbara A.
    Choi, Junsung
    Strosberg, Jonathan
    Kvols, Larry
    Hodul, Pamela
    Hoffe, Sarah
    Malafa, Mokenge P.
    CANCER CONTROL, 2017, 24 (05)
  • [39] Tumors of the Foot and Ankle: A Single-institution Experience
    Azevedo, Cristina P.
    Casanova, Jose M.
    Guerra, Marta G.
    Santos, Antonio L.
    Portela, Maria I.
    Tavares, Paulo F.
    JOURNAL OF FOOT & ANKLE SURGERY, 2013, 52 (02): : 147 - 152
  • [40] Tumors of the Ischiorectal Fossa: A Single-Institution Experience
    Zhu, Katherine J.
    Lee, Peter J.
    Austin, Kirk K. S.
    Solomon, Michael J.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (02) : 196 - 202
12345